Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Dow Jones Futures Rise With Key Data Due After Market Hit Resistance To Start 2023

Dow Jones futures: The market started 2023 where it left off: flashes of strength with reversals at resistance. Apple and Tesla stock dived.

Investors Business Daily

IBD Stock Of The Day: How These Issues In 2023 Could Spark, Or Slam, Eli Lilly Stock

Eli Lilly is the IBD Stock Of The Day as the company explores new methods of treating Alzheimer's and obesity, driving LLY stock near highs.

Investors Business Daily

The Battles Brewing That Could Stoke Already Red-Hot Eli Lilly Stock

Investors are closely watching two Eli Lilly battles that will unfold in 2023 as LLY stock continues a fevered streak, tacking on new highs.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Only 9 Big Growth Stocks Are Still Up This Year — Do You Own Any?

Apple, Amazon and Nvidia might pop into your head when you think S&P 500 growth stocks. But that's not where the growth is now.

Investors Business Daily

The Bullish Call Eli Lilly Made For Its Next-Gen Obesity Drug, A Rival To Novo, Amgen

Eli Lilly said Tuesday it plans to advance its next-generation obesity treatment into final-phase testing, but LLY stock dipped on guidance.

Investors Business Daily

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

Twitter to re-launch blue tick subscription service after first chaotic rollout backfired

The platform’s Blue subscriptions will return with $8 monthly charges, or $11 a month for iPhone users

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

How An Eli Lilly Decision Could Light Up The Red-Hot Obesity Landscape — Again

A key decision from Eli Lilly could alight the obesity treatment landscape again, an analyst said Friday as LLY stock lingers near a record.

Investors Business Daily

Here's What We Know So Far About Amgen's Obesity Drug As It Trails Novo Nordisk, Eli Lilly

Amgen is years behind rivals in developing an obesity treatment, but the company says its experimental drug could prove superior.

Investors Business Daily

Top executives explain how they achieve ESG goals amid backlash

How should companies reframe ESG initiatives amid controversy? These executives offer their strategies.

Fortune

Amgen Is The Underdog In Obesity Treatment — But It's Creeping Up On Novo Nordisk, Eli Lilly

Amgen stock dipped Thursday though the company unveiled promising results for its experimental obesity treatment.

Investors Business Daily

Twitter has lost 50 of its top 100 advertisers since Elon Musk took over, report says

Half of Twitter's top 100 advertisers appear to no longer be advertising on the website. A new report states that these 50 advertisers have spent almost $2 billion on Twitter ads since 2020.

WEKU

Elon Musk's Twitter Blue fiasco: Governments need to better regulate how companies use trademarks

Until recently, Twitter’s blue checkmark logo was (for better or worse) a trusted mark of authenticity. But under the façade of democratizing the platform, Elon Musk allowed the blue checkmark to be purchased by anyone — with unsurprisingly chaotic results.

The Conversation

‘More work to do’: Eli Lilly admits insulin pricing could be lower amid Twitter chaos

Furor over platform’s verified profiles may have done some good, but challenges still plague the site after a mass worker exodus

The Guardian - US

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Impersonation and parody: Shitposters satirically mock Elon Musk’s chaotic Twitter takeover

Posting on Twitter has changed since Elon Musk finalized his $44 billion takeover of the micro-blogging platform.

France 24

Profit, privacy and online safety: What's at stake with Twitter verification

The past week has seen Twitter announce – and quickly retract – new rules for authenticating user profiles, notably a controversial proposal to offer “blue check” verification to anyone willing to pay $8 a month. New owner Elon Musk, who on Tuesday set November 29 as the scheme’s relaunch date,…

Fortune

Balenciaga becomes the first major brand to delete its Twitter account

Fashion house Balenciaga has become the first brand to delete its Twitter account since the Musk acquisition.

Asharq Al-Awsat

Twitter Prank Spurs Unexpected Scrutiny of Insulin Prices

A Twitter imposter cost a US pharmaceutical giant billions of dollars, but the viral prank triggered another unexpected crisis -- a new wave of scrutiny of the high cost of its insulin. Authentic-looking fake accounts proliferated last week after Twitter rolled out a paid verification service, the latest in a…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

These Stocks Are Still Feeling The Heat From Elon Musk's Twitter Blue Dumpster Fire

Tesla Inc (NASDAQ: TSLA) CEO Elon Musk kicked off his first week at the helm of Twitter with a bang — but it backfired.<

Investors Business Daily

Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads

Eli Lilly reportedly is pulling advertising from Twitter after a fake account promised free insulin in a fiasco that depressed LLY stock.

Daily Mirror

Elon Musk fans spend £500,000 on GOAT monument in honour of controversial Twitter owner

The world's richest man will be presented with the statue at his Tesla HQ in Austin, Texas, next month

Fortune

Musk says Twitter Blue will ‘probably’ return by the ‘end of next week’ after trolling of companies, celebs by imposters

Pranked companies like Eli Lilly and Lockheed Martin will no doubt be watching closely.

ABC News

Pharmaceutical giant Eli Lilly & Co apologises after fake Twitter account says insulin is free as Elon Musk rolls back verification

The incident is among a wave of impersonations that prompted Twitter to make its relaunched premium service unavailable.

Fortune

No, insulin is not free: Eli Lilly is the latest high-profile casualty of Elon Musk’s Twitter verification mess

Eli Lilly shares fell after pranksters using Twitter Blue impersonated it and made a surprising claim—and this might be just the beginning.

Investors Business Daily

Patience At The Right Time Made LLY Stock A Swing Trading Winner

Patience is a virtue but knowing the right time to apply it helps make you money.

1 … 22 23 24 25

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.